W. Winkelmayer

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
W. C. Winkelmayer, W C Winkelmayer, Wolfgang C. Winkelmayer, Wolfgang Winkelmayer, Wolfgang C Winkelmayer
Publication record
523 papers · 24,262 citations · H-index 82

PAPERS

Managing the Symptom Burden Associated with Maintenance Dialysis: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
202391 citationsauthor #12
Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Treated Patients
20235 citationsauthor #11
QT-Prolonging Antibiotics, Serum-to-Dialysate Potassium Gradient, and Risk of Sudden Cardiac Death Among Patients Receiving Maintenance Hemodialysis
20239 citationsauthor #7
Vadadustat for treatment of anemia in patients with dialysis-dependent chronic kidney disease receiving peritoneal dialysis
202312 citationsauthor #13
Challenges in the Management of the Kidney Allograft: From Decline to Failure: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
202331 citationsauthor #12
Physiological Age by Artificial Intelligence–Enhanced Electrocardiograms as a Novel Risk Factor of Mortality in Kidney Transplant Candidates
20237 citationsauthor #10
Home dialysis: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
202375 citationsauthor #12
#5743 ALTERNATIVES TO DAYTIME IN-CENTER HEMODIALYSIS AND EMPLOYMENT AMONG PATIENTS WITH KIDNEY FAILURE
20230 citationsauthor #3
Trends and Perspectives for Improving Quality of Chronic Kidney Disease Care: Conclusions From a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
202362 citationsauthor #10
Hemodialysis Versus Peritoneal Dialysis Drug Expenditures: A Comparison Within the Private Insurance Market
20232 citationsauthor #4
Iron Sucrose and Blood Pressure Patterns During Hemodialysis.
20230 citationsauthor #2
Safety Endpoints With Vadadustat Versus Darbepoetin Alfa in Patients With Non–Dialysis-Dependent CKD: A Post Hoc Regional Analysis of the PRO2TECT Randomized Clinical Trial of ESA-Naïve Patients
20238 citationsauthor #1
Novel Anemia Therapies in CKD: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
202381 citationsauthor #12
Retraction notice to “Roxadustat for CKD Anemia – Starting the Jigsaw Puzzle, What Will the Finished Picture Show?” Kidney Int Rep. 2021;6:559–561
20220 citationsauthor #1
Fifty Years of a National Program for the Treatment of Kidney Failure.
20225 citationsauthor #3
US Renal Data System 2021 Annual Data Report: Epidemiology of Kidney Disease in the United States
2022199 citationsauthor #21
letter to the editor.
20220 citationsauthor #7
Natriuretic peptides, extracellular volume, and subclinical cardiovascular changes in chronic kidney disease stages 1–3: a pilot study
20223 citationsauthor #8
Child and caregiver perspectives on access to psychosocial and educational support in pediatric chronic kidney disease: a focus group study
202210 citationsauthor #21
Range and Consistency of Cardiovascular Outcomes Reported by Clinical Trials in Kidney Transplant Recipients: A Systematic Review
20221 citationsauthor #21
Sex Differences in Kidney Transplantation: Austria and the United States, 1978–2018
202218 citationsauthor #15
Azithromycin use increases the risk of sudden cardiac death in patients with hemodialysis-dependent kidney failure.
202212 citationsauthor #7
Overall Adverse Event Profile of Vadadustat versus Darbepoetin Alfa for the Treatment of Anemia Associated with Chronic Kidney Disease in Phase 3 Trials
20229 citationsauthor #9
Reproducibility of real-world evidence studies using clinical practice data to inform regulatory and coverage decisions
202272 citationsauthor #71
Proton pump inhibitors may enhance the risk of citalopram‐ and escitalopram‐associated sudden cardiac death among patients receiving hemodialysis
20228 citationsauthor #6
Apixaban for Patients With Atrial Fibrillation on Hemodialysis: A Multicenter Randomized Controlled Trial
2022146 citationsauthor #20
MO532: Cardiovascular Events in Patients With Non–Dialysis-Dependent Chronic Kidney Disease and Anemia: Regional Analysis of Patients Previously Treated With Erythropoiesis-Stimulating Agents in the PRO2TECT Trial
20221 citationsauthor #7
Cost Barriers to More Widespread Use of Peritoneal Dialysis in the United States.
20227 citationsauthor #4
Erythropoietic effects of vadadustat in patients with anemia associated with chronic kidney disease
202219 citationsauthor #19
MO536: Cardiovascular Events in Patients With Anemia Associated With Non–Dialysis-Dependent Chronic Kidney Disease: Regional Analysis of Patients not Previously Treated With Erythropoiesis-Stimulating Agents in The PRO2TECT Trial
20221 citationsauthor #1
A Comparison of US Medicare Expenditures for Hemodialysis and Peritoneal Dialysis
202214 citationsauthor #4
Nomenklatur für Nierenfunktion und Nierenkrankheiten – Durch Präzision und Verständlichkeit zu besserer Erfassung und Prognose
202210 citationsauthor #12
Updated US Prevalence Estimates for Chronic Kidney Disease Stage and Complications Using the New Race-Free Equation to Estimate Glomerular Filtration Rate
202215 citationsauthor #2
Associations of Serum and Dialysate Potassium Concentrations With Incident Atrial Fibrillation in a Cohort Study of Older US Persons Initiating Hemodialysis for Kidney Failure
20224 citationsauthor #8
The modifying effect of the serum-to-dialysate potassium gradient on the cardiovascular safety of SSRIs in the hemodialysis population: a pharmacoepidemiologic study.
20225 citationsauthor #6
Cardiovascular outcomes associated with prescription of sodium‐glucose co‐transporter‐2 inhibitors versus dipeptidyl peptidase‐4 inhibitors in patients with diabetes and chronic kidney disease
20224 citationsauthor #7
Association Between Preoperative Hemodialysis Timing and Postoperative Mortality in Patients With End-stage Kidney Disease.
202227 citationsauthor #5
Association between cause of kidney failure and fracture incidence in a national US dialysis population cohort study
20228 citationsauthor #5
Establishing a Core Outcome Measure for Peritoneal Dialysis-related Peritonitis: A Standardized Outcomes in Nephrology—Peritoneal Dialysis Consensus Workshop Report
20226 citationsauthor #39
Association of Bradycardia and Asystole Episodes with Dialytic Parameters: An Analysis of the Monitoring in Dialysis (MiD) Study
20222 citationsauthor #3
Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
2022128 citationsauthor #61
Patient-Reported Experiences with Dialysis Care and Provider Visit Frequency
20214 citationsauthor #4
Anticoagulation use and the risk of stroke and major bleeding in patients on hemodialysis: From the VIVALDI, a population‐based prospective cohort study
202121 citationsauthor #10
Anticoagulation in patients with kidney failure on dialysis: factor XI as a therapeutic target.
202136 citationsauthor #5
Roxadustat for CKD Anemia – Starting the Jigsaw Puzzle, What Will the Finished Picture Show?
20212 citationsauthor #1
MO539HEMATOLOGIC EFFICACY OF VADADUSTAT FOR ANEMIA IN PATIENTS WITH KIDNEY FAILURE ON DIALYSIS
20211 citationsauthor #1
Mortality, Kidney Failure, and Hospitalization Among Medicare Beneficiaries With CKD and Pulmonary Hypertension.
20216 citationsauthor #5
MO538 THE SHORT-TERM IMPACT OF HIGH DOSE INTRAVENOUS IRON USE ON RENAL FUNCTION IN PATIENTS WITH CHRONIC KIDNEY DISEASE AND IRON DEFICIENCY WITHOUT ANAEMIA - A POST-HOC ANALYSIS OF A MULTICENTRE RANDOMIZED CONTROLLED TRIAL*
20210 citationsauthor #6
Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis
202111 citationsauthor #2
MO114NEPHROLITHIASIS AS CAUSE OF KIDNEY FAILURE AND MAJOR CARDIOVASCULAR OUTCOMES IN INCIDENT DIALYSIS PATIENTS
20210 citationsauthor #2
Safety and Efficacy of Vadadustat for Anemia in Patients Undergoing Dialysis.
2021132 citationsauthor #25
Diseases of the Aorta and Kidney Disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
202117 citationsauthor #13
Cardiovascular Safety of Roxadustat in CKD Anemia: A Fig Leaf Named Noninferiority.
20217 citationsauthor #1
Black Race Coefficient in GFR Estimation and Diabetes Medications in CKD: National Estimates.
20218 citationsauthor #2
Controversies in Optimal Anemia Management: Conclusions from a Kidney Disease Improving Global Outcomes (KDIGO) Conference.
2021182 citationsauthor #12
Management and treatment of glomerular diseases (part 2): Conclusions From A Kidney Disease: Improving Global Outcomes (KDIGO) controversies conference
20213 citationsauthor #10
Harmonizing Acute and Chronic Kidney Disease Definition and Classification: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.
2021412 citationsauthor #6
Long-Term Exposures to Air Pollution and the Risk of Atrial Fibrillation in the Women’s Health Initiative Cohort
202120 citationsauthor #7
Ultrafiltration rate and incident atrial fibrillation among older individuals initiating hemodialysis.
202111 citationsauthor #4
Patient Health Outcomes following Dialysis Facility Closures in the United States
20213 citationsauthor #3
The impact of COVID‐19 on kidney transplantation and the kidney transplant recipient – One year into the pandemic
202152 citationsauthor #8
Central and peripheral arterial diseases in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference
202142 citationsauthor #13
Black Race Coefficient in GFR Estimation and Prevalence of CKD-Related Complications.
20211 citationsauthor #2
Kidney Function, Kidney Replacement Therapy, and Mortality in Men and Women
202117 citationsauthor #6
MO541HEMATOLOGIC EFFICACY OF VADADUSTAT FOR ANEMIA IN PATIENTS WITH NON--DIALYSIS-DEPENDENT CHRONIC KIDNEY DISEASE
20210 citationsauthor #7
Implantable Loop Recorder Monitoring and the Incidence of Previously Unrecognized Atrial Fibrillation in Patients on Hemodialysis
202111 citationsauthor #66
Renin–angiotensin system blocker discontinuation and adverse outcomes in chronic kidney disease
202122 citationsauthor #2
The Association of Pre-Kidney Transplant Dialysis Modality with de novo Posttransplant Heart Failure
20216 citationsauthor #6
Association of Blood Pressure Variability and Diuretics With Cardiovascular Events in Patients With Chronic Kidney Disease Stages 1-5.
202116 citationsauthor #8
Analysis of Respiratory Fluoroquinolones and the Risk of Sudden Cardiac Death Among Patients Receiving Hemodialysis.
202118 citationsauthor #7
Anticoagulation for stroke prevention in patients with atrial fibrillation on hemodialysis is associated with net-clinical harm
20210 citationsauthor #9
Vadadustat in Patients with Anemia and Non-Dialysis-Dependent CKD.
2021189 citationsauthor #28
A Global Accounting of Kidney Replacement Therapy.
20204 citationsauthor #2
Nomenclature for kidney function and disease—executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
202059 citationsauthor #7
Nomenclature for kidney function and disease: report of a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.
2020586 citationsauthor #41
Global Phase 3 programme of vadadustat for treatment of anaemia of chronic kidney disease: rationale, study design and baseline characteristics of dialysis-dependent patients in the INNO2VATE trials
202024 citationsauthor #14
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.
20208 citationsauthor #7
Patient and Caregiver Perspectives on Terms Used to Describe Kidney Health.
202043 citationsauthor #18
Hip Fracture Risk among Hemodialysis-Dependent Patients Prescribed Opioids and Gabapentinoids.
202014 citationsauthor #7
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
202012 citationsauthor #7
Establishing a Core Outcome Set for Peritoneal Dialysis: Report of the SONG-PD (Standardized Outcomes in Nephrology-Peritoneal Dialysis) Consensus Workshop.
2020155 citationsauthor #109
Controversies in acute kidney injury: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Conference
2020430 citationsauthor #14
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.
20205 citationsauthor #7
KDIGO Controversies Conference on onco-nephrology: kidney disease in hematological malignancies and the burden of cancer after kidney transplantation.
202015 citationsauthor #12
Direct oral anticoagulants in chronic kidney disease: an update.
202025 citationsauthor #3
Intradialytic Hypotension and Newly Recognized Peripheral Artery Disease in Patients Receiving Hemodialysis.
20208 citationsauthor #5
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
202053 citationsauthor #7
Nomenclature for kidney function and disease: executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) consensus conference
20205 citationsauthor #7
Forgotten Technology in the COVID-19 Pandemic: Filtration Properties of Cloth and Cloth Masks—A Narrative Review
202065 citationsauthor #12
Glycemic Control and Infections Among US Hemodialysis Patients With Diabetes Mellitus
20207 citationsauthor #7
Comparative effectiveness of branded vs. generic versions of antihypertensive, lipid-lowering and hypoglycemic substances: a population-wide cohort study
202033 citationsauthor #5
The Case for Early Identification and Intervention of Chronic Kidney Disease: Conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference.
2020476 citationsauthor #13
Web Exclusive Cloth Masks May Prevent Transmission of COVID-19: An Evidence-Based, Risk-Based Approach
20200 citationsauthor #9
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.
20203 citationsauthor #7
Adherence to the KDIGO Chronic Kidney Disease Guideline in Nephrology Practice across Countries
202045 citationsauthor #13
Hospitalization and Critical Illness in Chronic Kidney Disease
20203 citationsauthor #4
The landscape of renal replacement therapy in Veterans Affairs Medical Center intensive care units
20205 citationsauthor #8
Nomenclature for Kidney Function and Disease: Executive Summary and Glossary From a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference.
202015 citationsauthor #7
Nomenclature for kidney function and disease: Executive summary and glossary from a Kidney Disease: Improving Global Outcomes (KDIGO) Consensus Conference
20202 citationsauthor #7
Cardiovascular Safety and Efficacy of Vadadust for the Treatment of Anemia in Non-Dialysis Dependent CKD: Design and Baseline Characteristics.
20207 citationsauthor #20

TIMELINE

2000 136 citations

2001 133 citations

2002 924 citations

2003 652 citations

2004 1,015 citations

2005 459 citations

2006 1,118 citations

2007 635 citations

2008 944 citations

2009 196 citations

2010 217 citations

2011 1,250 citations

2012 1,013 citations

2013 1,229 citations

2014 1,126 citations

2015 1,277 citations

2016 883 citations

2017 1,681 citations

2018 1,463 citations

2019 2,716 citations

2020 2,866 citations

2021 1,239 citations

2022 734 citations

2023 383 citations

Unknown 0 citations

W. Winkelmayer

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT